SLC14A2

ITASCA, Ill.--( BUSINESS WIRE )-- Organ Recovery Systems (ORS) has been named a Gold winner in the Executive Team of the Year category for Best in Biz Awards 2022. The winners were selected based on scoring from independent judging panels comprised of journalists assembled from some of the most respected North American business magazines including Forbes to local newspapers, TV and radio outlets, and consumer, technology, and trade publications. In giving the award, judges highlighted ORS leadership’s unique ability to solve major unaddressed market needs in transplantation. The panelists stated they were “impressed with the CEO's (David Kravitz’s) vision, the revolutionary technology it brought to life, and the potential it has to positively affect so many lives around the world. Most impressive, however, was the flawless coming together of so many departments and the remarkable execution of the various members of the (ORS) executive team – that's what teamwork is all about!” The 12th annual awards program saw fierce competition among more than 700 entries from public and private companies of all sizes, industry sectors, and geographic regions throughout North America, ranging from some of the most iconic global brands and blue-chip companies in the global economy to innovative start-ups and resilient local companies. Judges underscored the winning companies’ visionary leadership, innovative strides in the use of new technologies, laudable employee diversity and inclusion programs and workplace best practices, community involvement, and monetary and time investments in the environment and corporate social responsibility programs. “We are honored to be recognized with the Gold award for Executive Team of the Year,” said David Kravitz, CEO of ORS, and in turn honor the donor families and worldwide clinical community on the front lines of donation and transplantation whose dedication and compassion save many thousands of lives each year. “As a leadership team (and this extends to all in our company), we are grateful and privileged with the opportunity to support their incredible efforts.” For the Best in Biz Awards official press release, visit: https://www.prweb.com/releases/2022/12/prweb19055748.htm About Organ Recovery Systems Organ Recovery Systems is a global market-leading provider of organ preservation products and services, supporting 320 transplant programs across 43 countries. Since its launch in 2003, LifePort Kidney Transporter has been employed in over 175,000 renal transplant procedures worldwide. Organ Recovery Systems’ proprietary LifePort platform has also been successfully designed to accommodate donor livers to help improve transplant outcomes for end-stage liver disease patients. LifePort Kidney and Liver Transporters are among a growing family of products and services developed by Organ Recovery Systems to support the Company’s mission of honoring donation as a gift of life, improving outcomes, and helping lower overall costs of care for end-stage organ disease.

When used to preserve donor livers from extended criteria donors, newly reported clinical trial outcomes show LifePort Liver Transporter improves graft and patient survival compared to static cold storage ITASCA, Ill.--(BUSINESS WIRE)-- Organ Recovery Systems (ORS) is celebrating the first liver transplants using the LifePort Liver Transporter (LLT) with Vasosol® at Rutgers Medical School in New Jersey and Northwestern Memorial Hospital in Chicago, Illinois. LLT uses oxygenated hypothermic machine perfusion (HMP) to limit organ damage during preservation, resulting in improved patient outcomes and increased utilization of lifesaving organs. This milestone took place as part of the FDA-authorized Continued Access study confirming the findings of the PILOT pivotal efficacy trial conducted over the last two years under a US FDA Investigational Device Exemption. This press release features multimedia. View the full release here: LifePort Liver Transporter is working to transform the preservation of donor livers. (Photo: Business Wire) Currently, around 11,000 Americans are waiting to receive a liver transplant. The traditional preservation method for donor organs is static cold storage, which limits the time and distance an organ can travel to the recipient transplant center. In contrast, LLT continuously perfuses a donor liver with a physiologic, oxygenated, nutrient-rich cold solution that keeps the organ healthy during preservation, potentially enabling donations over longer distances and extending the time the organ is viable for transplantation. Results of the multi-center PILOT trial presented at the 2022 American Association for the Study of Liver Disease (AASLD) Industry Colloquium showed a decreased length of patient hospital stay and reduced medical complications, leading to an improvement in graft function and patient survival. “Organ transplant involves a diverse team of people who are passionate about healthcare yet often find they must rush to deliver organs during their limited viability window. And that’s typically the case, even with the healthiest of donor organs,” said David Kravitz, CEO of ORS. “From the promising clinical evidence we’ve seen thus far, use of LLT makes the process easier on everyone involved, which gives patients on the waiting list a better chance of receiving a second chance at life.” The first livers preserved with the LLT under Continued Access were transplanted at University Hospital in Newark, NJ. Rutgers New Jersey Medical School is the first of a larger effort to further investigate the benefits of integrating LLT into existing transplant programs at participating medical centers. "I am extremely excited to finally be able to use oxygenated HMP for my patients as a targeted intervention to improve logistics, outcomes, and access to transplant by safely facilitating the use of Extended Criteria and DCD livers,” said Dr. James V. Guarrera, Professor of Surgery and Chief of Transplant and HPB Surgery at Rutgers New Jersey Medical School and Program Director at UH Liver Transplant. ABOUT ORGAN RECOVERY SYSTEMS Organ Recovery Systems is a global market-leading provider of organ preservation products and services, supporting 320 transplant programs across 43 countries. Since its launch in 2003, LifePort Kidney Transporter has been employed in over 175,000 renal transplant procedures worldwide. Organ Recovery Systems’ proprietary LifePort platform has also been successfully designed to accommodate donor livers to help improve transplant outcomes for end-stage liver disease patients. LifePort Kidney and Liver Transporters are among a growing family of products and services developed by Organ Recovery Systems to support the Company’s mission of honoring donation as a gift of life, improving outcomes, and helping lower overall costs of care for end-stage organ disease.

The LifePort Kidney Transporter selected as the exclusive hypothermic machine perfusion technology for donor kidney preservation at all national transplantation centers in Belgium The LifePort Kidney Transporter will be the exclusive provider of kidney preservation services at 7 transplant centers across Belgium. (Credit: Business Wire) Surgeons at Universitaire Ziekenhuizen and AZ Universitair Ziekenhuis have successfully performed the first kidney transplant procedures as part of a national contract with Organ Recovery Systems that designates the Company as the exclusive provider of preservation services for donor kidneys designated for clinical transplantation. The arrangement calls for the use of the Company’s proprietary LifePort Kidney Transporter at all transplant centers throughout Belgium along with logistical support services. LifePort Kidney Transporter is a novel medical device for organ preservation and transportation that employs hypothermic machine perfusion (HMP) to improve viability of a donor organ during the crucial window of time between organ donation and transplantation. Organ Recovery Systems was awarded the National “All-inclusive kidney preservation platform for hypothermic perfusion of donor kidneys for transplantation” by the National Belgian Transplant Society. Starting October 1st, 2022, through 2025, Organ Recovery Systems will provide all-inclusive preservation services for all Belgium-based transplant centers, including: – Universitaire Ziekenhuizen Leuven – AZ Universitair Ziekenhuis Antwerpen, Edegem – Universitair Ziekenhuis Brussel, Campus Jette – Université Libre de Bruxelles, Hôpital Erasme – Universitair Ziekenhuis Gent, Gent – Cliniques Universitaires Saint Luc, Bruxelles – Centre Hospitalier Universitaire, Liège “By establishing LifePort Kidney Transporter as the standard perfusion technology in Belgium, we’re going to show the world what the future of organ preservation looks like,” says Professor Tom Darius of Cliniques Universitaires Saint-Luc. “LifePort Kidney Transporter gives us the best shot at extending and improving the lives of people in need of a kidney transplant.” This announcement underlines Belgium’s position as a clinical leader in progressive transplant solutions after being one of the first European Nations to enact a program allowing the use of organs from individuals previously deemed ineligible for donation: those who died from circulatory death (DCD). Although organs from these donors were historically considered unviable, a retrospective analysis revealed that HMP, as enabled by LifePort Kidney Transporter, improved DCD kidney graft function compared to traditional static cold storage, making these organs more suitable for transplantation. Adopting LifePort Kidney Transporter as a standard of care for kidney preservation highlights Belgium’s commitment to increasing access to life-saving organs, improving patient outcomes, and honoring each donor and donor family for their precious gift. “We are deeply honored to see our LifePort technology contributing to the process of life-saving transplantation at a national level in Belgium,” said David Kravitz, CEO of Organ Recovery Systems. “As our Company’s mission is to help improve outcomes in transplantation, we are grateful to have the opportunity to partner with the National Belgian Transplant Society in giving more transplant waiting list patients a second chance at life.” Source: Company Press Release